SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2003 Commission File Number: 0-22286 Taro Pharmaceutical Industries Ltd. -------------------------------------------------------------------------------- (Translation of registrant's name into English) Italy House, Euro Park, Yakum 60972, Israel -------------------------------------------------------------------------------- (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F |X| Form 40-F |_| Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. Yes |_| No |X| The following is included in this Report on Form 6-K: 1. English translation of the registrant's filings in Hebrew with the Israeli Registrar of Companies during June 2003 which include: o Registrant's Annual Report; o Registrant's Directors Appointment Report; o Share Issuance Reports. 2 ANNUAL REPORT OF REGISTERED COMPANY ----------------------------------- -------------------------------------------------------------------------------- Company: Taro Pharmaceutical Industries Limited -------------------------------------------------------------------------------- No. of Company: 52-002290-6 -------------------------------------------------------------------------------- Address: 14 HaKitor Street, Haifa Bay -------------------------------------------------------------------------------- Annual Meeting Held on: June 5, 2003 -------------------------------------------------------------------------------- Report Updated until: June 19, 2003 -------------------------------------------------------------------------------- DISTRIBUTION OF SHARES ---------------------- -------------------------------------------- ----------------------- -------------------------------- ------------------------------ NAME OF SHARES SYMBOL OF SHARES NUMBER OF REGISTERED SHARES NUMBER OF ALLOCATED SHARES -------------------------------------------- ----------------------- -------------------------------- ------------------------------ Founders Shares Founders 2,600 2,600 -------------------------------------------- ----------------------- -------------------------------- ------------------------------ Ordinary Shares Ord. 200,000,000 29,134,536 -------------------------------------------- ----------------------- -------------------------------- ------------------------------ SHAREHOLDERS AND NUMBER OF SHARES THEY OWN ------------------------------------------ ---------------------------------- --------------------- --------------------- ----------------- ----------------- ----------------- SHAREHOLDER NAME ID NUMBER ADDRESS SYMBOL OF SHARES NUMBER OF SHARES AMOUNT AS YET UNPAID FOR SHARES ---------------------------------- --------------------- --------------------- ----------------- ----------------- ----------------- Morley & Co.,Inc. Company Registered 16 Stonewall Lane Founders 2,600 in New-York, USA Mamaroneck, NY 10543 USA ---------------------------------- --------------------- --------------------- ----------------- ----------------- ----------------- Other Shareholders - - - Ordinary 29,134,536 according to the attached list ---------------------------------- --------------------- --------------------- ----------------- ----------------- ----------------- DETAILS OF THE DIRECTORS APPOINTED ---------------------------------- ---------------------------- ------------------------- ----------------------------------------------------- ----------------------- DIRECTOR'S NAME ID# ADDRESS DATE OF APPOINTMENT ---------------------------- ------------------------- ----------------------------------------------------- ------- ------- ------- Michael Friedman 065483450 21 Harevadim St., Jerusalem 93391, ISRAEL 05 06 03 ---------------------------- ------------------------- ----------------------------------------------------- ------- ------- ------- Gad Keren 050264035 11 Simha Holtzberg, Kiryat Ono 55426, ISRAEL 05 06 03 ---------------------------- ------------------------- ----------------------------------------------------- ------- ------- ------- Heather Douglas CAN VH. 706945 106 The Kings Way, Toronto, ONT M8X 2V1, CANADA 05 06 03 ---------------------------- ------------------------- ----------------------------------------------------- ------- ------- ------- Eric Johnston CAN VG. 133978 111 Percy St., Ottowa, ONT K1R 6C5, CANADA 05 06 03 ---------------------------- ------------------------- ----------------------------------------------------- ------- ------- ------- Aaron Levitt USA 140398367 233 Beech Court, River Edge, NJ 07661, USA 05 06 03 ---------------------------- ------------------------- ----------------------------------------------------- ------- ------- ------- Barrie Levitt USA 140787555 16 Stone Wall Lane, Mamaroneck, NY 10543, USA 05 06 03 ---------------------------- ------------------------- ----------------------------------------------------- ------- ------- ------- Tal Levitt USA 141060456 300 Mercer St., #21I, New York, NY 10003, USA 05 06 03 ---------------------------- ------------------------- ----------------------------------------------------- ------- ------- ------- Daniel Moros USA 140655646 50 Iselin Terrace, Larchmont, NY 10538, USA 05 06 03 ---------------------------- ------------------------- ----------------------------------------------------- ------- ------- ------- Myron Strober USA 151452233 8871 Boatswain Dr., Boyton Beach, FL 33436, USA 05 06 03 ---------------------------- ------------------------- ----------------------------------------------------- ------- ------- ------- Irit Hausner 005089877 19 Har HaGilboa, Kiryat Ono 55024, ISRAEL 30 07 98 ---------------------------- ------------------------- ----------------------------------------------------- ------- ------- ------- Aryeh Barak 054499645 27 Bnei Moshe, Tel Aviv 62308, ISRAEL 27 08 98 ---------------------------- ------------------------- ----------------------------------------------------- ------- ------- ------- 3 -------------------------------------------------------------------------------- DETAILS OF DIRECTORS NO LONGER IN OFFICE -------------------------------------------------------------------------------- ---------------- ------------------------ ------------------------------------- NAME ID NUMBER DATE OF TERMINATION ---------------- ------------------------ ------------- ------------- --------- Eric Hills 48231914 20 10 02 ---------------- ------------------------ ------------- ------------- --------- * DECEASED MARK [X] IN THE CORRECT PLACE ----------------------------- [X] No change in details reported regarding foreign directors according to regulation 16 of the aforesaid regulations ___ Change in details has been reported regarding a foreign director and relevant required documents have been attached to the Annual Report according to regulation 16 of the aforesaid regulations. Fullfillment of Section 171(c) to the law - The directorate has approved the ------------------------------------------- financial statements; mark [X] if carried out [X] Fullfillment of Section 173 to the law [mark [X] next to the correct choice] -------------------------------------- (1) The financial statements were presented at the recent Annual Meeting as required [X] (2) If the company is not obligated to hold an Annual Meeting according to section 61(a) to the law, specify whether the financial statements were submitted to the shareholders according to section 61(b) to the law ____. (3) The company is not obligated to submit financial statements at the Annual Meeting as stated in section 172(g) to the law ____. Auditor [mark [X] and fill in the details in the correct choice] ------- (1) The company has an auditor as specified in section 154 of the law [X]. Name of auditor - KOST FORER & GABAY, address: AMINADAV 3, TEL-AVIV 61575 ------------------ -------------------------- (2) The company does not have an auditor ____. (3) The company is an inactive company, as signified in section 158(a) and it has been decided at the General Meeting that an auditor will not be appointed ____. Company Manager --------------- If the company has a general manager or head business manager or position which is responsible for the general management of the company, indicate name, address and ID number. Name: SAMUEL RUBINSTEIN Address: 106A DAVID HAMELECH ST., HERZELIYA PITUAH 46661 ID number: 5736034 Office Phone: 09-9711800 Financial Statements -------------------- A private company for which section 175 of the law applies, will attach financial statements. Declaration by Company Directorate according to section 174 ----------------------------------------------------------- [X] I hereby declare in the name of the directorate that the instructions in section 173(a) to the law have been carried out and that the financial statements were ____ brought before/ [X] were sent to the shareholders on 30.04.03. Signature and Declaration: -------------------------- I hereby declare that the details above are complete and correct and that I am authorized by the Board of Directors of the Company to sign this Report. Name Arye Barak I.D. number 054499645 Signature (-) 4 REPORT OF CHANGE OF DIRECTORS ----------------------------- ---------------------------------- --------------------------------------------- Company: Taro Pharmaceutical Industries Limited ---------------------------------- --------------------------------------------- No. of Company: 52-002290-6 ---------------------------------- --------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------ DETAILS OF THE DIRECTORS APPOINTED DATE OF DIRECTOR'S NAME APPOINTMENT ---------------- CORPORATION ------------------------ PRIVATE FAMILY NAME ID# GENDER ADDRESS YEAR MONTH DAY ----------------- ------------ ---------------- -------- -------------------------------------------------- ------- -------- ------- Michael Friedman 065483450 Male 21 Harevadim St., Jerusalem 93391, Israel 05 06 03 ----------------- ------------ ---------------- -------- -------------------------------------------------- ------- -------- ------- Gad Keren 050264035 Male 11 Simha Holtzberg, Kiryat Ono 55426, ISRAEL 05 06 03 ----------------- ------------ ---------------- -------- -------------------------------------------------- ------- -------- ------- Heather Douglas CAN VH 706945 Female 106 The Kings Way, Toronto, ONT M8X 2V1, CANADA 05 06 03 ----------------- ------------ ---------------- -------- -------------------------------------------------- ------- -------- ------- Eric Johnston CAN VG 133978 Male 111 Percy St., Ottowa, ONT K1R 6C5, CANADA 05 06 03 ----------------- ------------ ---------------- -------- -------------------------------------------------- ------- -------- ------- Aaron Levitt USA 140398367 Male 233 Beech Court, River Edge, NJ 07661, USA 05 06 03 ----------------- ------------ ---------------- -------- -------------------------------------------------- ------- -------- ------- Barrie Levitt USA 140787555 Male 16 Stone Wall Lane, Mamaroneck, NY 10543, USA 05 06 03 ----------------- ------------ ---------------- -------- -------------------------------------------------- ------- -------- ------- Tal Levitt USA 141060456 Female 300 Mercer St., #21I, New York, NY 10003, USA 05 06 03 ----------------- ------------ ---------------- -------- -------------------------------------------------- ------- -------- ------- Daniel Moros USA 140655646 Male 50 Iselin Terrace, Larchmont, NY 10538, USA 05 06 03 ----------------- ------------ ---------------- -------- -------------------------------------------------- ------- -------- ------- Myron Strober USA 151452233 Male 8871 Boatswain Dr., Boyton Beach, FL 33436, USA 05 06 03 ----------------- ------------ ---------------- -------- -------------------------------------------------- ------- -------- ------- Irit Hausner 005089877 Female 19 Har HaGilboa, Kiryat Ono 55024, ISRAEL 30 7 98 ----------------- ------------ ---------------- -------- -------------------------------------------------- ------- -------- ------- Aryeh Barak 054499645 Male 27 Bnei Moshe, Tel Aviv 62308, ISRAEL 27 8 98 ----------------- ------------ ---------------- -------- -------------------------------------------------- ------- -------- ------- 5 -------------------------------------------------------------------------------- DETAILS OF DIRECTOR IN OFFICE ON BEHALF OF A CORPORATION -------------------------------------------------------------------------------- NAME OF DIRECTOR --------------------- ---------------------- NAME OF CORPORATION PRIVATE FAMILY ID NUMBER ADDRESS --------------------- --------------------- ---------------------- -------------------- -------------------- --------------------- --------------------- ---------------------- -------------------- -------------------- --------------------- --------------------- ---------------------- -------------------- -------------------- -------------------------------------------------------------------------------------------------------------------- DETAILS OF DIRECTORS NO LONGER IN OFFICE -------------------------------------------------------------------------------------------------------------------- ------------------ ----------------------------- ----------------------------- ------------------------------------- NAME DATE OF CHANGE ---------------- -------------- ------------- ------------- --------- FAMILY PRIVATE CORPORATION ID NUMBER YEAR MONTH DAY ---------------- -------------- ----------------------- --------------------- ------------- ------------- --------- ---------------- -------------- ----------------------- --------------------- ------------- ------------- --------- ---------------- -------------- ----------------------- --------------------- ------------- ------------- --------- ---------------- -------------- ----------------------- --------------------- ------------- ------------- --------- The changes detailed in this form have been |X| / have not been ___ recorded in the Register of Directors, according to section 224 of the law (check the correct choice), or give comments __________________. ----------------------------------------------------- Reported by: MARC COLES ----------------------------------------------------- I.D. number 015383888 ----------------------------------------------------- Title: VP AND GENERAL COUNSEL ----------------------------------------------------- Date: JUNE 23, 2003 ----------------------------------------------------- 6 REPORT OF SHARE ISSUANCE ------------------------ Company: Taro Pharmaceutical Industries Limited Date of Issuance: April 14, 2003 No. of Company: 52-002290-6 Name of Shares: Ordinary Symbol of Shares: Ord. Par Value: NIS 0.0001 No. of Shares Issued: 4,575 For Cash Consideration: 4,575 Additional Holders of Ordinary Shares Par value No. of shares Price per share I.D.number: US citizen ID 634460689 Driver Licence DOB07-06-44 Shareholder: Alexander Cossin 0.0001 2,500 11.70 Address: 1 Spruce Drive 500 11.43 Tuxedo NY 10987 U.S.A. 875 21.25 700 59.26 Cash allocation Amount regarded as paid 2,500 - 11.70NIS; 500 - 11.43NIS; for each share: 875 - 21.25NIS; 700 - 59.26NIS Reported by: Kevin Connelly I.D. number U.S. 140853346 Title: Chief Financial Officer Date: April 20, 2003 7 REPORT OF SHARE ISSUANCE ------------------------ Company: Taro Pharmaceutical Industries Limited Date of Issuance: April 16, 2003 No. of Company: 52-002290-6 Name of Shares: Ordinary Symbol of Shares: Ord. Par Value: NIS 0.0001 No. of Shares Issued: 1,000 For Cash Consideration: 1,000 Additional Holders of Ordinary Shares Par value No. of shares Price per share I.D. number: USA Resident Shareholder: Howard Rutman 0.0001 1,000 17.17 Address: 1199 Park Avenue New York, NY 10128 U.S.A Cash allocation Amount regarded as paid 1,000 - 17.17NIS for each share: Reported by: Kevin Connelly I.D. number U.S. 140853346 Title: Chief Financial Officer Date: April 29, 2003 8 REPORT OF SHARE ISSUANCE ------------------------ Company: Taro Pharmaceutical Industries Limited Date of Issuance: April 21, 2003 No. of Company: 52-002290-6 Name of Shares: Ordinary Symbol of Shares: Ord. Par Value: NIS 0.0001 No. of Shares Issued: 2,000 For Cash Consideration: 2,000 Additional Holders of Ordinary Shares Par value No. of shares Price per share I.D. number: Canadian Passport VM 678149 Shareholder: Rachel Marcks 0.0001 2,000 16.03 Address: 603 Clark Avenue West, Unit #1 Thornhill, ONT L4J 8P9 CANADA Cash allocation Amount regarded as paid 2,000 - 16.03NIS for each share: Reported by: Kevin Connelly I.D. number U.S. 140853346 Title: Chief Financial Officer Date: April 27, 2003 9 REPORT OF SHARE ISSUANCE ------------------------ Company: Taro Pharmaceutical Industries Limited Date of Issuance: April 21, 2003 No. of Company: 52-002290-6 Name of Shares: Ordinary Symbol of Shares: Ord. Par Value: NIS 0.0001 No. of Shares Issued: 1,250 For Cash Consideration: 1,250 Additional Holders of Ordinary Shares Par value No. of shares Price per share I.D. number: Canadian resident Shareholder: Teresa Staley 0.0001 1,250 39.93 Address: 825 Norwick Road Newmarket, ONT L3X 1K8 CANADA Cash allocation Amount regarded as paid 1,250 - 39.93NIS for each share: Reported by: Kevin Connelly I.D. number U.S. 140853346 Title: Chief Financial Officer Date: April 27, 2003 10 REPORT OF SHARE ISSUANCE ------------------------ Company: Taro Pharmaceutical Industries Limited Date of Issuance: April 21, 2003 No. of Company: 52-002290-6 Name of Shares: Ordinary Symbol of Shares: Ord. Par Value: NIS 0.0001 No. of Shares Issued: 25 For Cash Consideration: 25 Additional Holders of Ordinary Shares Par value No. of shares Price per share I.D. number: Canadian citizen SO484-29604-81108 Shareholder: Godfredo Santiago 0.0001 25 11.40 Address: 516 Ashprior Avenue Mississauga, ONT L5R 3N1 CANADA Cash allocation Amount regarded as paid 25 - 11.40NIS for each share: Reported by: Kevin Connelly I.D. number U.S. 140853346 Title: Chief Financial Officer Date: April 27, 2003 11 REPORT OF SHARE ISSUANCE ------------------------ Company: Taro Pharmaceutical Industries Limited Date of Issuance: April 21, 2003 No. of Company: 52-002290-6 Name of Shares: Ordinary Symbol of Shares: Ord. Par Value: NIS 0.0001 No. of Shares Issued: 76 For Cash Consideration: 76 Additional Holders of Ordinary Shares Par value No. of shares Price per share I.D. number: Canadian citizen R-6889-27424-11203 Shareholder: Gary Rowley 0.0001 50 11.40 Address: 34 Leander Street 26 11.17 Bramdea, ONT L6S 3M6 CANADA Cash allocation Amount regarded as paid 50 - 11.40NIS; 26 - 11.17NIS for each share: Reported by: Kevin Connelly I.D. number U.S. 140853346 Title: Chief Financial Officer Date: April 27, 2003 12 REPORT OF SHARE ISSUANCE ------------------------ Company: Taro Pharmaceutical Industries Limited Date of Issuance: April 21, 2003 No. of Company: 52-002290-6 Name of Shares: Ordinary Symbol of Shares: Ord. Par Value: NIS 0.0001 No. of Shares Issued: 1,000 For Cash Consideration: 1,000 Additional Holders of Ordinary Shares Par value No. of shares Price per share I.D. number: Drivers License B2386-42553-70914 Shareholder: Martin Belitz 0.0001 1,000 23.60 Address: 28 Hawleaf Crescent Willowdale, ONT M2H 3H4 CANADA Cash allocation Amount regarded as paid 1,000 - 23.60NIS for each share: Reported by: Kevin Connelly I.D. number U.S. 140853346 Title: Chief Financial Officer Date: April 27, 2003 13 REPORT OF SHARE ISSUANCE ------------------------ Company: Taro Pharmaceutical Industries Limited Date of Issuance: April 23, 2003 No. of Company: 52-002290-6 Name of Shares: Ordinary Symbol of Shares: Ord. Par Value: NIS 0.0001 No. of Shares Issued: 50 For Cash Consideration: 50 Additional Holders of Ordinary Shares Par value No. of shares Price per share I.D. number: US Passport # 954042356 Shareholder: Jacquelyn Castaldo 0.0001 50 11.49 Address: 805 N. Barry Av. Mamaroneck, NY 10543 U.S.A Cash allocation Amount regarded as paid 50 - 11.49NIS for each share: Reported by: Kevin Connelly I.D. number U.S. 140853346 Title: Chief Financial Officer Date: May 11, 2003 14 REPORT OF SHARE ISSUANCE ------------------------ Company: Taro Pharmaceutical Industries Limited Date of Issuance: April 23, 2003 No. of Company: 52-002290-6 Name of Shares: Ordinary Symbol of Shares: Ord. Par Value: NIS 0.0001 No. of Shares Issued: 74 For Cash Consideration: 74 Additional Holders of Ordinary Shares Par value No. of shares Price per share I.D. number: Canadian Resident 43-05-179299 Shareholder: Ray Harding 0.0001 74 11.40 Address: 108-703 Edgehill Drive Barrie, ONT L4N 5A3 CANADA Cash allocation Amount regarded as paid 74 - 11.40NIS for each share: Reported by: Kevin Connelly I.D. number U.S 140853346 Title: Chief Financial Officer Date: April 27, 2003 15 REPORT OF SHARE ISSUANCE ------------------------ Company: Taro Pharmaceutical Industries Limited Date of Issuance: April 24, 2003 No. of Company: 52-002290-6 Name of Shares: Ordinary Symbol of Shares: Ord. Par Value: NIS 0.0001 No. of Shares Issued: 2,900 For Cash Consideration: 2,900 Additional Holders of Ordinary Shares Par value No. of shares Price per share I.D. number: Israeli ID # 67467506 Shareholder: Tzvi Tal 0.0001 250 10.86 Address: 25 Golda Meir St., 250 11.14 Haifa 34982 ISRAEL 500 11.36 500 21.13 1,000 54.36 400 58.92 Cash allocation Amount regarded as paid 250 - 10.86NIS; 250 - 11.14NIS; 500 - 11.36NIS; for each share: 500 - 21.13NIS; 1,000 - 54.36NIS; 400 - 58.92NIS Reported by: Kevin Connelly I.D. number U.S 140853346 Title: Chief Financial Officer Date: April 27, 2003 16 REPORT OF SHARE ISSUANCE ------------------------ Company: Taro Pharmaceutical Industries Limited Date of Issuance: April 28, 2003 No. of Company: 52-002290-6 Name of Shares: Ordinary Symbol of Shares: Ord. Par Value: NIS 0.0001 No. of Shares Issued: 1,000 For Cash Consideration: 1,000 Additional Holders of Ordinary Shares Par value No. of shares Price per share I.D. number: Israeli ID # 049156532 Shareholder: Hannah Bayer 1,000 67.76 Address: 4 Hatut St. Ramot Hashavim ISRAEL Cash allocation Amount regarded as paid 1,000 - 67.76NIS for each share: Reported by: Kevin Connelly I.D. number U.S. 140853346 Title: Chief Financial Officer Date: April 30, 2003 17 REPORT OF SHARE ISSUANCE ------------------------ Company: Taro Pharmaceutical Industries Limited Date of Issuance: April 30, 2003 No. of Company: 52-002290-6 Name of Shares: Ordinary Symbol of Shares: Ord. Par Value: NIS 0.0001 No. of Shares Issued: 25 For Cash Consideration: 25 Additional Holders of Ordinary Shares Par value No. of shares Price per share I.D. number: Drivers License # 9400-3806-4004 Shareholder: Kevin Murphy 0.0001 25 11.23 Address: 2101 4470 Tucana Court Mississauga, ONT L5R 3K8 CANADA Cash allocation Amount regarded as paid 25 - 11.23NIS for each share: Reported by: Kevin Connelly I.D. number U.S 140853346 Title: Chief Financial Officer Date: May 5, 2003 18 REPORT OF SHARE ISSUANCE ------------------------ Company: Taro Pharmaceutical Industries Limited Date of Issuance: May 2, 2003 No. of Company: 52-002290-6 Name of Shares: Ordinary Symbol of Shares: Ord. Par Value: NIS 0.0001 No. of Shares Issued: 50 For Cash Consideration: 50 Additional Holders of Ordinary Shares Par value No. of shares Price per share I.D.number: Drivers License # H6015-41076-35315 Shareholder: Josey Hobbs 0.0001 50 11.17 Address: 2563 Proudfoot St. Mississauga, ONT L5C 2N9 CANADA Cash allocation Amount regarded as paid 50 - 11.17NIS for each share: Reported by: Kevin Connelly I.D. number U.S. 140853346 Title: Chief Financial Officer Date: May 5, 2003 19 REPORT OF SHARE ISSUANCE ------------------------ Company: Taro Pharmaceutical Industries Limited Date of Issuance: April 28, 2003 No. of Company: 52-002290-6 Name of Shares: Ordinary Symbol of Shares: Ord. Par Value: NIS 0.0001 No. of Shares Issued: 25 For Cash Consideration: 25 Additional Holders of Ordinary Shares Par value No. of shares Price per share I.D. number: Canadian Birth Certificate ZO 37720 Shareholder: Louanne Powless 0.0001 25 11.38 Address: 34 Albemarle Court Brampton, ONT L6Z 1R4 CANADA Cash allocation Amount regarded as paid 25 - 11.38NIS for each share: Reported by: Kevin Connelly I.D. number U.S. 140853346 Title: Chief Financial Officer Date: April 29, 2003 20 REPORT OF SHARE ISSUANCE ------------------------ Company: Taro Pharmaceutical Industries Limited Date of Issuance: May 5, 2003 No. of Company: 52-002290-6 Name of Shares: Ordinary Symbol of Shares: Ord. Par Value: NIS 0.0001 No. of Shares Issued: 1,750 For Cash Consideration: 1,750 Additional Holders of Ordinary Shares Par value No. of shares Price per share I.D. number: Israeli ID # 030590079 Shareholder: Yohanan Dichter 0.0001 150 10.66 Address: 5 Caspri 150 10.93 Haifa 34673 ISRAEL 250 11.16 800 53.37 400 57.85 Cash allocation Amount regarded as paid 150 - 10.66NIS; 150 - 10.93NIS; 250 - for each share: 11.16NIS; 800 - 53.37NIS; 400 - 57.85NIS Reported by: Kevin Connelly I.D. number U.S. 140853346 Title: Chief Financial Officer Date: May 14, 2003 21 REPORT OF SHARE ISSUANCE ------------------------ Company: Taro Pharmaceutical Industries Limited Date of Issuance: April 25, 2003 No. of Company: 52-002290-6 Name of Shares: Ordinary Symbol of Shares: Ord. Par Value: NIS 0.0001 No. of Shares Issued: 4,000 For Cash Consideration: 4,000 Additional Holders of Ordinary Shares Par value No. of shares Price per share I.D. number: Drivers License # 06801-32075-55219 Shareholder: Heather Douglas 0.0001 4,000 13.38 Address: 106 The Kingsway Toronto, ONT M8X 2V1 CANADA Cash allocation Amount regarded as paid 4,000 - 13.38NIS for each share: Reported by: Kevin Connelly I.D. number U.S. 140853346 Title: Chief Financial Officer Date: May 14, 2003 22 REPORT OF SHARE ISSUANCE ------------------------ Company: Taro Pharmaceutical Industries Limited Date of Issuance: April 28, 2003 No. of Company: 52-002290-6 Name of Shares: Ordinary Symbol of Shares: Ord. Par Value: NIS 0.0001 No. of Shares Issued: 25 For Cash Consideration: 25 Additional Holders of Ordinary Shares Par value No. of shares Price per share I.D. number: Canadian Citizen Shareholder: Sharon Nicholson 0.0001 25 11.38 Address: 183 Manley Lane Milton, ONT L9T 5P1 CANADA Cash allocation Amount regarded as paid 25 - 11.38NIS for each share: Reported by: Kevin Connelly I.D. number U.S. 140853346 Title: Chief Financial Officer Date: April 29, 2003 23 REPORT OF SHARE ISSUANCE ------------------------ Company: Taro Pharmaceutical Industries Limited Date of Issuance: May 5, 2003 No. of Company: 52-002290-6 Name of Shares: Ordinary Symbol of Shares: Ord. Par Value: NIS 0.0001 No. of Shares Issued: 400 For Cash Consideration: 400 Additional Holders of Ordinary Shares Par value No. of shares Price per share I.D. number: US Passport # 093241410 Shareholder: Walter Jenkins 0.0001 400 57.85 Address: 56 Duke Drive Carmel, NY 10512 U.S.A Cash allocation Amount regarded as paid 400 - 57.85NIS for each share: Reported by: Kevin Connelly I.D. number U.S. 140853346 Title: Chief Financial Officer Date: May 14, 2003 24 REPORT OF SHARE ISSUANCE ------------------------ Company: Taro Pharmaceutical Industries Limited Date of Issuance: May 7, 2003 No. of Company: 52-002290-6 Name of Shares: Ordinary Symbol of Shares: Ord. Par Value: NIS 0.0001 No. of Shares Issued: 500 For Cash Consideration: 500 Additional Holders of Ordinary Shares Par value No. of shares Price per share I.D. number: Israeli ID # 056683154 Shareholder: Orna Scheffer 0.0001 125 10.61 Address: 18 Bnei Brit St., 125 10.88 Hod Hasharon 45265 ISRAEL 250 11.10 Cash allocation Amount regarded as paid 125 - 10.61NIS; 125 - 10.88 NIS; for each share: 250 - 11.10 NIS Reported by: Kevin Connelly I.D. number U.S. 140853346 Title: Chief Financial Officer Date: May 14, 2003 25 REPORT OF SHARE ISSUANCE ------------------------ Company: Taro Pharmaceutical Industries Limited Date of Issuance: May 7, 2003 No. of Company: 52-002290-6 Name of Shares: Ordinary Symbol of Shares: Ord. Par Value: NIS 0.0001 No. of Shares Issued: 750 For Cash Consideration: 750 Additional Holders of Ordinary Shares Par value No. of shares Price per share I.D. number: US citizen # 111892362 Shareholder: Kaplana Rao 0.0001 750 11.91 Address: 20 Shafter Avenue Albertson, NY 11507 U.S.A Cash allocation Amount regarded as paid 750 - 11.91NIS for each share: Reported by: Kevin Connelly I.D. number U.S. 140853346 Title: Chief Financial Officer Date: May 14, 2003 26 REPORT OF SHARE ISSUANCE ------------------------ Company: Taro Pharmaceutical Industries Limited Date of Issuance: May 7, 2003 No. of Company: 52-002290-6 Name of Shares: Ordinary Symbol of Shares: Ord. Par Value: NIS 0.0001 No. of Shares Issued: 800 For Cash Consideration: 800 Additional Holders of Ordinary Shares Par value No. of shares Price per share I.D. number: US Citizen Shareholder: Myron Strober 0.0001 800 105.79 Address: 8871 Boatswain Dr. Boynton Beach, FL 33436 U.S.A Cash allocation Amount regarded as paid 800 - 105.79NIS for each share: Reported by: Kevin Connelly I.D. number U.S. 140853346 Title: Chief Financial Officer Date: May 14, 2003 27 REPORT OF SHARE ISSUANCE ------------------------ Company: Taro Pharmaceutical Industries Limited Date of Issuance: May 9, 2003 No. of Company: 52-002290-6 Name of Shares: Ordinary Symbol of Shares: Ord. Par Value: NIS 0.0001 No. of Shares Issued: 25 For Cash Consideration: 25 Additional Holders of Ordinary Shares Par value No. of shares Price per share I.D. number: Canadian ID # 3632306 Shareholder: Nick Spatari 0.0001 25 11.06 Address: 43 Coral Gable Dr. Toronto, ONT M9M 1N8 CANADA Cash allocation Amount regarded as paid 25 - 11.06NIS for each share: Reported by: Kevin Connelly I.D. number U.S. 140853346 Title: Chief Financial Officer Date: May 28, 2003 28 REPORT OF SHARE ISSUANCE ------------------------ Company: Taro Pharmaceutical Industries Limited Date of Issuance: May 12, 2003 No. of Company: 52-002290-6 Name of Shares: Ordinary Symbol of Shares: Ord. Par Value: NIS 0.0001 No. of Shares Issued: 500 For Cash Consideration: 500 Additional Holders of Ordinary Shares Par value No. of shares Price per share I.D. number: Israeli ID # 049156532 Shareholder: Hannah Bayer 0.0001 500 66.17 Address: 4 Hatut St. Ramot Hashavim ISRAEL Cash allocation Amount regarded as paid 500 - 66.17NIS for each share: Reported by: Kevin Connelly I.D. number U.S. 140853346 Title: Chief Financial Officer Date: May 14, 2003 29 REPORT OF SHARE ISSUANCE ------------------------ Company: Taro Pharmaceutical Industries Limited Date of Issuance: May 22, 2003 No. of Company: 52-002290-6 Name of Shares: Ordinary Symbol of Shares: Ord. Par Value: NIS 0.0001 No. of Shares Issued: 1,800 For Cash Consideration: 1,800 Additional Holders of Ordinary Shares Par value No. of shares Price per share I.D. number: US Passport # 092826547 Shareholder: Zvi Rosenthal 0.0001 150 11.10 Address: 98 Walnut Drive 250 11.33 Tenafly, NJ 07670 U.S.A 1,000 21.07 400 58.75 Cash allocation Amount regarded as paid 150 - 11.10NIS; 250 - 11.33 NIS; for each share: 1,000 - 21.07 NIS; 400 - 58.75 NIS Reported by: Kevin Connelly I.D. number U.S. 140853346 Title: Chief Financial Officer Date: May 25, 2003 30 REPORT OF SHARE ISSUANCE ------------------------ Company: Taro Pharmaceutical Industries Limited Date of Issuance: May 13, 2003 No. of Company: 52-002290-6 Name of Shares: Ordinary Symbol of Shares: Ord. Par Value: NIS 0.0001 No. of Shares Issued: 4,500 For Cash Consideration: 4,500 Additional Holders of Ordinary Shares Par value No. of shares Price per share I.D. number: Israeli ID # 4823142 Shareholder: Hermona Hills 0.0001 4,500 15.26 Address: 26 Givat Downes Haifa 34345 ISRAEL Cash allocation Amount regarded as paid 4,500 - 15.26NIS for each share: Reported by: Kevin Connelly I.D. number U.S. 140853346 Title: Chief Financial Officer Date: May 14, 2003 31 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Taro Pharmaceutical Industries Ltd. Date: July 10, 2003 By:/s/ Kevin Connelly ---------------------------------- Kevin Connelly Senior Vice President and Chief Financial Officer 32